High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

Sebastiaan Somers, Patty Jansen, Hendrik Veelken, Maarten Vermeer, Willem Kraan, Anne-Roos Schrader, Ward Posthuma, Marcel Nijland, Arjan Diepstra, Marie Jose Kersten, Steven Pals, Arjen Cleven, Joost Vermaat

    Research output: Contribution to journalMeeting AbstractAcademic

    Original languageEnglish
    Number of pages2
    JournalBlood
    Volume130
    Publication statusPublished - 7-Dec-2017
    Event59th Annual Meeting of the American-Society-of-Hematology (ASH) - Atlanta, United States
    Duration: 9-Dec-201712-Dec-2017

    Cite this